Sentrx Safety Solutions provides pharmacovigilance services to the life sciences industry. Pharmacovigilance is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. The company was founded in 1995 and is headquartered in Little Falls, NJ (www.sentrx.com).
Fairmount Partners introduced the parties and advised both Telerx and Sentrx on the transaction. Neal McCarthy, Managing Director of Fairmount Partners, led the team which represented Sentrx and Edison Ventures. “It was a pleasure to represent Mike O’Gorman, CEO of Sentrx and the partners at Edison Ventures. Sentrx will be an excellent addition to Telerx,” said Mr. McCarthy.
Fairmount Partners specializes in assisting companies in mergers and acquisitions, capital raising and strategic advice. Fairmount completes most of its transactions in its key focus areas: Technology & Software, IT & Business Services, Healthcare, and Consumer & Industrial, and has completed transactions throughout North and South America, Europe and Asia. The firm is based in the Philadelphia suburb of West Conshohocken (www.fairmountpartners.com).
“We are extremely pleased to add the Sentrx team, led by Mike O’Gorman, CEO, and their industry leading pharmacovigilance capabilities to our Telerx services platform. Working with Fairmount Partners, we will continue to seek highly complementary acquisitions,” said Howard Snyder, VP of Mergers and Acquisitions for Telerx.
Telerx provides services for the management of complex and sensitive interactions in the healthcare marketplace including, access & reimbursement, product recalls and critical events, quality and compliance and patient assistance. Telerx is headquartered in Horsham, PA (www.telerx.com).
Edison Ventures invests from $5 million to $10 million in information technology businesses that have revenues from $5 million to $20 million. In addition to providing expansion capital, Edison also invests in management buyouts, recapitalizations, spinouts and secondary stock purchases. The firm was founded in 1986 and is based in Lawrenceville, NJ (www.edisonventure.com).
© 2013 PEPD • Private Equity’s Leading News Magazine • 4-10-13